Boston Scientific Corp [NYSE: BSX] price plunged by -0.60 percent to reach at -$0.62.
A sum of 7919434 shares traded at recent session while its average daily volume was at 7.41M shares. Boston Scientific Corp shares reached a high of $104.555 and dropped to a low of $103.16 until finishing in the latest session at $103.16.
The one-year BSX stock forecast points to a potential upside of 14.52. The average equity rating for BSX stock is currently 1.34, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Boston Scientific Corp [BSX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BSX shares is $120.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BSX stock is a recommendation set at 1.34. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Boston Scientific Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 16, 2025. The new note on the price target was released on April 16, 2025, representing the official price target for Boston Scientific Corp stock. Previously, the target price had yet another raise to $108, while Deutsche Bank analysts kept a Buy rating on BSX stock.
The Price to Book ratio for the last quarter was 6.87, with the Price to Cash per share for the same quarter was set at 0.56. Price to Free Cash Flow for BSX in the course of the last twelve months was 50.64 with Quick ratio for the last quarter at 0.88.
BSX Stock Performance Analysis:
Boston Scientific Corp [BSX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.31. With this latest performance, BSX shares gained by 1.84% in over the last four-week period, additionally plugging by 4.56% over the last 6 months – not to mention a rise of 15.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BSX stock in for the last two-week period is set at 48.70, with the RSI for the last a single of trading hit 1.95, and the three-weeks RSI is set at 1.97 for Boston Scientific Corp [BSX]. The present Moving Average for the last 50 days of trading for this stock 103.44, while it was recorded at 103.68 for the last single week of trading, and 97.10 for the last 200 days.
Insight into Boston Scientific Corp Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Boston Scientific Corp [BSX] shares currently have an operating margin of 16.56% and a Gross Margin at 61.84%. Boston Scientific Corp’s Net Margin is presently recorded at 11.58%.
Boston Scientific Corp (BSX) Capital Structure & Debt Analysis
According to recent financial data for Boston Scientific Corp. ( BSX), the Return on Equity (ROE) stands at 9.65%, suggesting modest shareholder returns. The Return on Assets (ROA) is 5.29%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Boston Scientific Corp’s Return on Invested Capital (ROIC) is 6.13%, showcasing its effectiveness in deploying capital for earnings.
Boston Scientific Corp (BSX) Efficiency & Liquidity Metrics
Based on Boston Scientific Corp’s (BSX) latest financial statements, the Debt-to-Equity Ratio is 0.53%, indicating its reliance on debt financing relative to shareholder equity.
Boston Scientific Corp (BSX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Boston Scientific Corp. (BSX) effectively leverages its workforce, generating an average of $38301.89 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.45% and a Quick Ratio of 0.88%, indicating strong ability to cover short-term liabilities.
BSX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BSX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Boston Scientific Corp go to 14.04%.
Boston Scientific Corp [BSX] Institutonal Ownership Details
There are presently around $93.57%, or 93.74% of BSX stock, in the hands of institutional investors. The top three institutional holders of BSX stocks are: FMR LLC with ownership of 141.46 million shares, which is approximately 9.6192%. VANGUARD GROUP INC, holding 129.87 million shares of the stock with an approximate value of $$10.0 billion in BSX stocks shares; and VANGUARD GROUP INC, currently with $$9.74 billion in BSX stock with ownership which is approximately 8.5964%.
